These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28536844)

  • 1. Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.
    Yin X; Wang M; Wang H; Deng H; He T; Tan Y; Zhu Z; Wu Z; Hu S; Li Z
    Amino Acids; 2017 Aug; 49(8):1325-1335. PubMed ID: 28536844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor.
    Deng H; Wang H; Wang M; Li Z; Wu Z
    Mol Pharm; 2015 Aug; 12(8):3054-61. PubMed ID: 26162008
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Wu W; Yu F; Zhang P; Bu T; Fu J; Ai S; You Q; Shi L; Shao G; Wang F; Hodolic M; Guo H
    J Nucl Med; 2022 Sep; 63(9):1394-1400. PubMed ID: 35177423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
    Wang JG; Li NN; Li HN; Cui L; Wang P
    Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of
    Marenco M; Lodola L; Persico MG; Frangipane V; Facoetti A; Aprile C; Hodolič M
    Curr Pharm Biotechnol; 2018; 19(9):754-759. PubMed ID: 30160211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of
    Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
    Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
    Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients.
    Buchegger F; Bonvin F; Kosinski M; Schaffland AO; Prior J; Reubi JC; Bläuenstein P; Tourwé D; García Garayoa E; Bischof Delaloye A
    J Nucl Med; 2003 Oct; 44(10):1649-54. PubMed ID: 14530481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
    J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
    Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Baum RP; Singh A; Schuchardt C; Kulkarni HR; Klette I; Wiessalla S; Osterkamp F; Reineke U; Smerling C
    J Nucl Med; 2018 May; 59(5):809-814. PubMed ID: 29025990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the Profile of [
    Kanellopoulos P; Nock BA; Krenning EP; Maina T
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours.
    García-Garayoa E; Bläuenstein P; Blanc A; Maes V; Tourwé D; Schubiger PA
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):37-47. PubMed ID: 18690434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer.
    Hodolic M; Ambrosini V; Fanti S
    Nucl Med Commun; 2020 May; 41(5):411-415. PubMed ID: 32168264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Neurotensin Receptor in Prostate Cancer With
    Deng H; Wang H; Zhang H; Wang M; Giglio B; Ma X; Jiang G; Yuan H; Wu Z; Li Z
    Mol Imaging; 2017; 16():1536012117711369. PubMed ID: 28849698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors.
    Bakirtzi K; Hatziapostolou M; Karagiannides I; Polytarchou C; Jaeger S; Iliopoulos D; Pothoulakis C
    Gastroenterology; 2011 Nov; 141(5):1749-61.e1. PubMed ID: 21806946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody.
    Torres JB; Knight JC; Mosley MJ; Kersemans V; Koustoulidou S; Allen D; Kinchesh P; Smart S; Cornelissen B
    Mol Imaging Biol; 2018 Apr; 20(2):292-299. PubMed ID: 28842811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.